Patients and methods: Study records on epidemic, clinical characteristics and Kras-mutation at codon 12, 13 in exon 2 in patients with colorectal cancer treated at K hospital. Results: The percentage of Kras-2 mutation was 42%; codon 12, 13 and both mutation were 8%, 28%, 8%, respectively.